NCT06804200View on ClinicalTrials.gov

Prospective Validation of AKI Prediction

Not yet recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Acute Kidney Injury
Trial Locations (1)

14642

Golisano Children's Hospital at Strong, Rochester

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Adam C Dziorny

OTHER

NCT06804200 - Prospective Validation of AKI Prediction | Biotech Hunter | Biotech Hunter